Location History:
- Holte, DK (2010 - 2014)
- Soelleroed Holte, DK (2014)
Company Filing History:
Years Active: 2010-2014
Title: Innovator Hans-Henrik Kristensen Hoegenhaug: A Pioneer in Antimicrobial Peptides
Introduction: Hans-Henrik Kristensen Hoegenhaug is a notable inventor based in Holte, Denmark. With a strong focus on antimicrobial peptides, he has made significant contributions to the field of biotechnology, holding four patents that underscore his innovative approach to addressing medical challenges.
Latest Patents: Hoegenhaug's latest inventions include "Antimicrobial peptide variants and polynucleotides encoding same," which explores variations of a parent antimicrobial peptide. This invention expands on the utility of polynucleotides that encode these variants, addressing their application in various constructs, vectors, and host cells. Additionally, he has developed a treatment method for urinary tract infections (UTIs), particularly those caused by uropathogenic bacterial strains. This method utilizes a beta-hairpin antimicrobial polypeptide derived from murine polychaetes and includes different variants of Arenicin, showcasing his commitment to advancing therapeutic strategies.
Career Highlights: Throughout his career, Hoegenhaug has been associated with prominent biotechnology firms, including Novozymes and Adenium Biotech. His work in these organizations has been pivotal in driving research and development in the biopharmaceutical sector, focusing on antimicrobial solutions.
Collaborations: Hoegenhaug has collaborated with distinguished colleagues such as Dorotea Raventos Segura and Per Holse Mygind. These partnerships have fostered an environment of innovation, contributing to the advancements in the understanding and application of antimicrobial peptides.
Conclusion: Hans-Henrik Kristensen Hoegenhaug stands out as a significant figure in the realm of biotechnology, particularly in the development of antimicrobial peptides. His inventions not only reflect his innovative spirit but also promise to enhance treatments for infections, thus making a valuable impact in medical science. His ongoing work continues to inspire future research and development in this crucial field.